| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/02/1998 | WO1998028264A1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 07/02/1998 | WO1998028007A1 Stable liquid interferon formulations |
| 07/02/1998 | WO1998027998A1 Remedies for cerebral ischemic diseases |
| 07/02/1998 | WO1998027994A1 Proteins and compositions for modulating mitosis |
| 07/02/1998 | WO1998027932A2 Cerebellum and embryo specific protein |
| 07/02/1998 | WO1998027930A2 New use of aminopiperazine derivatives |
| 07/02/1998 | WO1998027813A1 Methods for treating insulin resistance and identifying patients at risk for the disease |
| 07/02/1998 | CA2276149A1 Methods for treating insulin resistance and identifying patients at risk for the disease |
| 07/02/1998 | CA2276090A1 Recombinant n-smases and nucleic acids encoding same |
| 07/02/1998 | CA2276034A1 Oxygen or sulfur containing 5-membered heteroaromatics as factor xa inhibitors |
| 07/02/1998 | CA2275796A1 Nitrogen containing heteroaromatics as factor xa inhibitors |
| 07/02/1998 | CA2275683A1 Meiosis regulating compounds |
| 07/02/1998 | CA2275665A1 Nitromethylthiobenzene derivatives as aldose reductase inhibitors |
| 07/02/1998 | CA2275540A1 Cerebellum and embryo specific protein |
| 07/02/1998 | CA2275318A1 New use of aminopiperazine derivatives |
| 07/02/1998 | CA2275183A1 Ob fusion protein compositions and methods |
| 07/02/1998 | CA2274899A1 New use of dipeptide derivatives |
| 07/02/1998 | CA2274734A1 Proteins and compositions for modulating mitosis |
| 07/02/1998 | CA2274675A1 Vegf-b/receptor complex and uses thereof |
| 07/02/1998 | CA2272453A1 Benzoylalkyl-1,2,3,6-tetrahydropyridines |
| 07/02/1998 | CA2272305A1 Cycloalkyl, lactam, lactone and related compounds as .beta.-amyloid peptide release inhibitors |
| 07/02/1998 | CA2271715A1 Peptide antagonists of dp transcription factors |
| 07/01/1998 | EP0850939A1 Ellipticine derivatives, their preparation and pharmaceutical compositions containing them |
| 07/01/1998 | EP0850924A1 Aromatic diselenides and selenosulphides for use as antioxidant agents |
| 07/01/1998 | EP0850647A1 Application of 11-substituted steroids for the preparation of medicaments with dissociated estrogenic activity |
| 07/01/1998 | EP0850319A1 Method for modulating cell apoptosis |
| 07/01/1998 | EP0850308A2 Hcv ns3 protein fragments having helicase activity and improved solubility |
| 07/01/1998 | EP0850250A1 Ubiquitin conjugating enzymes having transcriptional repressor activity |
| 07/01/1998 | EP0850240A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 07/01/1998 | EP0850236A1 Piperazino derivatives as neurokinin antagonists |
| 07/01/1998 | EP0850235A1 Quinolein-2(1h)-one derivatives as serotonin antagonists |
| 07/01/1998 | EP0850234A1 Novel heterocyclic compounds for the treatment of pain and use thereof |
| 07/01/1998 | EP0850233A1 Retinoids and methods of use of same |
| 07/01/1998 | EP0850221A1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| 07/01/1998 | EP0850215A1 N-(aroyl)glycine hydroxamic acid derivatives and related compounds |
| 07/01/1998 | EP0850064A1 Compositions with anti-apoptotic activity, containing a mixture of phospholipids |
| 07/01/1998 | EP0850062A1 Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating human malignancies |
| 07/01/1998 | EP0691972B1 FURO 3,2-b]PYRIDINES AND THIENO 3,2-b]PYRIDINES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS |
| 07/01/1998 | EP0646127B1 Polypeptide bombesin antagonists |
| 07/01/1998 | EP0594581B1 Production of glycosides, especially of steroidal glycosides |
| 07/01/1998 | CN1186518A Human vascular endothelial growth factor 2 |
| 07/01/1998 | CN1186515A 转化生长因子αHI Transforming growth factor αHI |
| 07/01/1998 | CN1186501A Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4 |
| 07/01/1998 | CN1186499A Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 07/01/1998 | CN1186495A Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 07/01/1998 | CN1186443A Radiolabeled peptides for diagnosis and therapy |
| 07/01/1998 | CN1186438A Methods and compositions for healing and repair of connective tissue attachment |
| 07/01/1998 | CN1186434A Pharmaceutical composition comprising proteinase inhibitor and monoglyceride |
| 07/01/1998 | CN1186431A Compositions and methods using nitroxides in combination with biocompatible macromolecules |
| 07/01/1998 | CN1186074A New imidazoline compounds, process for preparing them and pharmaceutical compositions containing them |
| 07/01/1998 | CN1185948A Inhibitor for generation of 3-deoxyglucurone |
| 07/01/1998 | CN1038937C Preparation of ergoline-8-carboxamides |
| 07/01/1998 | CN1038931C Preparation of medicinal compositions useful as anta-gonists of excitatory amino acid neuro-transmitters and/or as blockers of calcium channels |
| 07/01/1998 | CN1038929C Chelants processing ortho ligating functionality and complexes thereof |
| 07/01/1998 | CN1038928C Method for producing mono-fluoreinated derivatives of N-propargyl-1-aminoindan |
| 07/01/1998 | CN1038903C Agent for increasing somatostatin or for inhibiting decrcase of somatostatin |
| 06/30/1998 | US5773646 Integrin inhibitors |
| 06/30/1998 | US5773644 Cyclopropyl alkanoic acid derivatives |
| 06/30/1998 | US5773612 Indol-2-one derivatives |
| 06/30/1998 | US5773586 Conjugates comprising truncated keratinocyte growth factor (KGF) having increased biological activity and a toxin |
| 06/30/1998 | US5773580 Human protein kinase c inhibitor homolog |
| 06/30/1998 | US5773479 Atherosclerosis, tamoxifen |
| 06/30/1998 | US5773477 Combination therapy to treat osteoporosis - polyphosphonates and estrogen agonists |
| 06/30/1998 | US5773467 Inhibitors of phosphodiesterases and tumor necrosis factor |
| 06/30/1998 | US5773465 Tartronic acids, their acetalic ethers and o-esters |
| 06/30/1998 | US5773455 Inhibitors of prenyl transferases |
| 06/30/1998 | US5773452 Alzheimer's disease; cognition activators |
| 06/30/1998 | US5773448 Nervous system disorders |
| 06/30/1998 | US5773444 Quinazolines as inhibitors of endothelin converting enzyme |
| 06/30/1998 | US5773436 Use of serotonin antagonists for treating fibromyalgia |
| 06/30/1998 | US5773432 Using certain 17-difluoromethylene-estratrienes in the treatment and prevention of premature occlusive arterial disease |
| 06/30/1998 | US5773430 Reduces tissue destruction during inflammation resulting from the activity of human leukocyte elastase |
| 06/30/1998 | US5773412 Use of peptides for altering αV β3 -mediated binding |
| 06/30/1998 | US5773231 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 06/30/1998 | US5773209 Prevention of formation of oxidized polyunsaturated fatty acid, suppression of gene expression through redox sensitive pathways |
| 06/30/1998 | US5773000 Therapeutic treatment of clostridium difficile associated diseases |
| 06/30/1998 | US5772997 Monoclonal antibodies directed to the HER2 receptor |
| 06/30/1998 | US5772990 Composition for slowing down the loss of hair based on pyrimidine N-oxides triaminosubstituted or their sulfoconjugated |
| 06/30/1998 | CA2239926A1 N-linked sulfonamides of heterocyclic thioesters |
| 06/30/1998 | CA2139947C Calcium channel blocking polypeptide from agelenopsis aperta |
| 06/30/1998 | CA2085344C Injectable pharmaceutical composition |
| 06/27/1998 | CA2225906A1 3-deoxyglucosone production inhibitor |
| 06/25/1998 | WO1998027108A2 New amide compounds and their use as nitric oxide synthase inhibitors |
| 06/25/1998 | WO1998027098A1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE |
| 06/25/1998 | WO1998027086A1 Novel heterocyclic substituted pyrrolidine amide derivatives |
| 06/25/1998 | WO1998027081A1 Sulphonamide derivatives, process for their preparation, and their use as medicaments |
| 06/25/1998 | WO1998027073A1 Asymmetric synthesis of benzoxazinones |
| 06/25/1998 | WO1998027069A1 Piperazine compounds as inhibitors of mmp or tnf |
| 06/25/1998 | WO1998027065A1 Modulators of proteins with phosphotyrosine recognition units |
| 06/25/1998 | WO1998026795A1 Use of peptides for improving the incorporation of skin grafts |
| 06/25/1998 | WO1998026794A1 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
| 06/25/1998 | WO1998026790A1 Mycobacterium vaccae for down-regulation of the th2 activity of the immune system |
| 06/25/1998 | WO1998026781A1 Method of treating or inhibiting neutropenia |
| 06/25/1998 | WO1998026776A1 Method for treating renal failure |
| 06/25/1998 | WO1998022100A3 New use for 1,3-propanediol derivatives |
| 06/25/1998 | WO1998012220A3 Novel tumor proteins |
| 06/25/1998 | WO1998010068A3 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals |
| 06/25/1998 | CA2275610A1 Modulators of proteins with phosphotyrosine recognition units |
| 06/25/1998 | CA2275492A1 Sulphonamide derivatives, process for their preparation, and their use as medicaments |
| 06/25/1998 | CA2275478A1 Piperazine compounds as inhibitors of mmp or tnf |